Krsnaa Diagnostics · NSE: KRSNAA · BSE: 543328

Q2 FY24 results · Jul–Sep 2023

Krsnaa Diagnostics reported revenue from operations of ₹155.45 crore (up 26.4% from Q2 FY23) and net profit of ₹10.50 crore (down 31.6% from Q2 FY23) for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.

Consolidated · ₹ crore
ItemQ2 FY24Q2 FY23YoYQ1 FY24QoQ
Revenue from operations155.45122.94+26.4%139.58+11.4%
Other income4.164.27−2.6%4.22−1.5%
Total income159.61127.21+25.5%143.80+11.0%
Profit before tax13.4220.16−33.4%17.89−25.0%
Net profit for the period10.5015.34−31.6%14.64−28.3%
EPS, basic (₹)3.355.73−41.5%4.66−28.1%
Net margin (%)6.812.510.5
Standalone · ₹ crore
ItemQ2 FY24Q2 FY23YoYQ1 FY24QoQ
Revenue from operations146.85120.72+21.6%132.28+11.0%
Other income4.164.27−2.7%4.22−1.5%
Total income151.01124.99+20.8%136.51+10.6%
Profit before tax14.1823.69−40.1%18.72−24.2%
Net profit for the period11.3117.97−37.1%15.25−25.9%
EPS, basic (₹)3.605.73−37.2%4.86−25.9%
Net margin (%)7.714.911.5
Consolidated
Filed with BSE
18 Nov 2023, 09:00 IST
Board meeting
03 Nov 2023
Period
01 Jul 2023 to 30 Sep 2023
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
18 Nov 2023, 09:00 IST
Board meeting
03 Nov 2023
Period
01 Jul 2023 to 30 Sep 2023
Review status
Unaudited
Source
XBRL filing on BSE